Wolverine Trading
TAK icon

Wolverine Trading’s Takeda Pharmaceutical TAK Stock Holding History

Wolverine Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,700
Closed -$338K – 6810
2021
Q3 		$338K Sell
20,700
-3,400
-14% -$57.1K ﹤0.01% 4529
2021
Q2 		$406K Sell
24,100
-25,700
-52% -$437K ﹤0.01% 3998
2021
Q1 		$914K Buy
49,800
+16,600
+50% +$299K ﹤0.01% 2877
2020
Q4 		$604K Buy
33,200
+5,800
+21% +$102K ﹤0.01% 2935
2020
Q3 		$497K Sell
27,400
-4,000
-13% -$72.8K ﹤0.01% 2830
2020
Q2 		$569K Sell
31,400
-11,200
-26% -$201K ﹤0.01% 2597
2020
Q1 		$666K Buy
+42,600
New +$772K ﹤0.01% 2344
2019
Q3 		– Sell
-33,400
Closed -$591K – 4980
2019
Q2 		$591K Buy
33,400
+13,600
+69% +$247K ﹤0.01% 2542
2019
Q1 		$403K Buy
+19,800
New +$398K ﹤0.01% 3009

Other funds holding TAK

MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wolverine Trading's TAK Position: Q4 2021 in Review

Wolverine Trading sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 10,376 shares — an estimated $169K sold.

Wolverine Trading first reported a position in TAK in Q4 2020 and held it in 4 quarters. The position peaked at $599K in Q4 2020. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • Wolverine Trading reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 10,376 Takeda Pharmaceutical shares in Q4 2021, an estimated $169K.
  • Wolverine Trading first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 4 quarters.
  • Wolverine Trading's Takeda Pharmaceutical position peaked at $599K in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.